Clinical trial
Sildenafil for Chronic Obstructive Pulmonary Disease
NCT00104637 · Kawut, Steven, MD, Other · Completed
Key facts
| NCT number | NCT00104637 |
|---|---|
| Title | Sildenafil for Chronic Obstructive Pulmonary Disease |
| Official title | A Double-blind, Placebo-controlled, Crossover Study of Sildenafil in Patients With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Kawut, Steven, MD, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive, Emphysema |
| Intervention type | Drug |
| Interventions | sildenafil citrate, Placebo |
| Enrollment | 10 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Mar 4, 2005 |
| Last update posted | May 21, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: